IMVT
IMVT
NASDAQ · Biotechnology

Immunovant Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$37.62
-0.48 (-1.26%)
As of Jun 23, 9:52 PM ET ·
Analyst Consensus
Strong Buy
24
Analysts
High
Coverage
Buy 18 75%
Hold 6 25%
Sell 0 0%
Price Target
Analyst Price Target +62.0% upside
Low Target $43.15
Average Target $60.94
High Target $94.48
Current Price $37.62
Current
$37.62
Target
$60.94
$43.15 $60.94 avg $94.48
Scenario Analysis
Bear Case
$43.15
14.7%
Low target
Base Case
$60.94
+62.0%
Avg target
Bull Case
$94.48
+151.1%
High target
Risk/Reward
10.3x
Highly favorable
Price in Context
52-Week High
$36.29
3.7% from high
52-Week Low
$14.32
+162.7% from low
50-Day SMA
$25.99
+44.7% vs SMA
200-Day SMA
$19.59
+92.0% vs SMA
RSI (14)
49.5
Neutral
Target vs 52W High
$60.94
+67.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%